LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Sells/Trims (3)
AQR
$110.7M
sold
Alger
$92.7M
sold
Bank of America
$212.0M
sold
Sells (1)
Koch Lori
$13K
sold
Sells (1)
No tracked top-trader positions in DD as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.76 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 23, 2026
EPS expected
$1.85 to $2.01
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $1.88 / $1.76Alpha Vantage | +6.82% beat | $1.82B No estimate | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $1.65 / $1.45Alpha Vantage | +13.79% beat | $1.68B No estimate | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $1.38 / $1.29Alpha Vantage | +6.98% beat | $1.69B No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $3.27 / $2.94Alpha Vantage | +11.22% beat | $3.07B No estimate | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $3.36 / $3.18Alpha Vantage | +5.66% beat | $3.26B No estimate | Unavailable |
| Mar 31, 2025 | May 2, 2025 | $3.09 / $2.86Alpha Vantage | +8.04% beat | $3.07B No estimate | Unavailable |
| Dec 31, 2024 | Feb 11, 2025 | $3.39 / $2.94Alpha Vantage | +15.31% beat | $3.09B No estimate | Unavailable |
| Sep 30, 2024 | Nov 5, 2024 | $3.54 / $3.09Alpha Vantage | +14.56% beat | $2.86B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.07B | $1.69B | $1.68B | $1.82B |
| Cost of what it sold | $2.00B | $1.17B | $1.08B | $1.18B |
| Gross profit | $1.07B | $527.0M | $602.0M | $639.0M |
| What it spent | ||||
| Research and development | $140.0M | $38.0M | $47.0M | $42.0M |
| Sales and admin | $387.0M | $262.0M | $255.0M | $269.0M |
| Other operating costs | — | — | $114.0M | $72.0M |
| Total operating expenses | $527.0M | $300.0M | $416.0M | $383.0M |
| What was left | ||||
| Operating profit | $547.0M | $227.0M | $186.0M | $256.0M |
| Interest on debt | $99.0M | $61.0M | $40.0M | $41.0M |
| Profit before tax | $327.0M | -$66.0M | $181.0M | $266.0M |
| Tax | $19.0M | $42.0M | $31.0M | $75.0M |
| Net profit | -$123.0M | -$126.0M | $161.0M | $143.0M |
| EBITDA | $683.0M | $154.0M | $306.0M | $359.0M |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
DuPont de Nemours, Inc. Estimates – NYSE:DD
NeutralOct 23Corteva declares $0.05 per share quarterly dividend By Investing.com
Leans bullishOct 23Corteva declares $0.05 per share quarterly dividend By Investing.com
NeutralOct 23DuPont de Nemours, Inc. Estimates – XETR:6D8
NeutralOct 23Quadrant Capital Group LLC Acquires 8,922 Shares of DuPont de Nemours, Inc. $DD
Leans bullishOct 23DuPont de Nemours, Inc. (DD) Launches AmberChrom SIL for Peptide Purification
BullishOct 22A new material from DuPont is designed to help purify GLP-1 and other peptide medicines
BullishOct 22TI Trust Inc. Acquires 12,040 Shares of DuPont de Nemours, Inc. $DD
Leans bullishOct 22
